我如何治疗Ph+急性淋巴细胞白血病
Melanie Castro-Mollo1, Daniel J DeAngelo1, Marlise R Luskin1
1Division of Leukemia, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Future oncology (London, England)
|September 8, 2025
概括
费城染色体阳性急性淋巴细胞白血病 (Ph+ ALL) 治疗已通过氨酸激酶抑制剂 (TKIs) 和免疫疗法进展,改善了结果. 造血干细胞移植 (HSCT) 对于高风险的Ph+ ALL患者至关重要.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
背景情况:
- 费城染色体阳性急性淋巴细胞白血病 (Ph+ ALL) 是由BCR:ABL1融合基因驱动的.
- 该基因产生氨酸激酶,导致疾病和化疗耐药性.
- 传统的化疗和HSCT历来为Ph+ALL提供了糟糕的治疗结果.
研究的目的:
- 审查Ph+ALL治疗的最新进展.
- 突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出
- 讨论免疫疗法和造血干细胞移植 (HSCT) 的作用.
主要方法:
- 关于Ph+ALL治疗近期进展的文献综述.
- 重点是氨酸激酶抑制剂 (TKI) 和免疫疗法.
- 对血造干细胞移植 (HSCT) 的演变作用的分析.
主要成果:
- 氨酸激酶抑制剂 (TKIs) 已经彻底改变了Ph+ ALL治疗,改善了生存率.
- 免疫疗法,如blinatumomab,提供了新的治疗途径,可能减少化疗和HSCT需求.
- 造血干细胞移植 (HSCT) 对于某些高风险的Ph+ ALL病例至关重要.
结论:
- 在管理Ph+ALL时,技术知识是必不可少的.
- 免疫疗法正在成为一种变革性的治疗方式.
- 风险适应性治疗,包括合理使用HSCT,是最佳Ph+ALL管理的关键.
相关概念视频
01:30Acute Pharyngitis
3.9K
Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
3.9K
02:50Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K